Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian…

By B. Dahlöf, Peter S Sever, Neil R. Poulter, H. Wedel, D. Beevers, M. Caulfield, R. Collins, S. Kjeldsen, A. Kristinsson, Gordon T. McInnes and 4 more. The Lancet, 2005

2,332 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/386609a20116eafc22a7776f9840703e04a7b9a1

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. S. Laurent
2. Michael F. O'Rourke
3. H. S. Boudier
4. B. K. Pedersen
5. B. Saltin

Citations in the corpus

• Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical Outcomes: Principal Results of the Conduit Artery Function Evaluation (CAFE) Study (2006, methodology): “Finally, ASCOT showed significant reductions in total coronary events, cardiovascular death, and stroke with amlodipine±perindopril-based therapy compared with atenolol±thiazide-based therapy.(21) An analysis of the factors contributing to the differential clinical outcomes in ASCOT concluded that c”
• Measurement of Blood Pressure in Humans (2019, neutral): “Devices originally developed for self-measurement in the home have been adapted for office use.(40) However, because these devices were not specifically designed for the office setting, they may lack durability and reliability.”
• 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) (2007, background): “In fact, in all trials in which the design permitted or prescribed the simultaneous use of diuretics, beta-blockers or ACE inhibitors [269,299,301, 423], calcium antagonists were not inferior to comparative therapies in preventing heart failure.”